| Package | hl7.fhir.us.nhsn-ade |
| Type | ImplementationGuide |
| Id | Id |
| FHIR Version | R4 |
| Source | http://hl7.org/fhir/us/nhsn-ade/https://build.fhir.org/ig/HL7/fhir-nhsn-ade-ig/ImplementationGuide-hl7.fhir.us.nhsn-ade.html |
| Url | http://hl7.org/fhir/us/nhsn-ade/ImplementationGuide/hl7.fhir.us.nhsn-ade |
| Version | 0.1.0 |
| Status | draft |
| Date | 2022-01-10T05:39:41+00:00 |
| Name | AdverseDrugEventsGlycemicControl |
| Title | NHSN Reporting: Adverse Drug Events - Glycemic Control |
| Experimental | False |
| Realm | us |
| Authority | hl7 |
| Description | Adverse drug events (ADEs) are among the most common causes of iatrogenic harm in U.S. hospitals. An effort to establish an EHR- and vendor-neutral standard for submitting ADE data to NHSN is being sought to improve patient safety and facilitate quality improvement effort. This promising initiative enables EHRs of acute care facilities to serve as source systems for reporting ADE data to the National Healthcare Safety Network (NHSN) via industry electronic messages. This initiative leverages NHSN’s longstanding experience working closely with the Health Level Seven (HL7) standards development organization and HL7 consultants in developing and maintaining electronic healthcare-associated and antibiotic use and resistance reporting implementation guidance for EHRs and infection surveillance system vendors in the acute care arena. That experience, and the working relationships developed over a 10-year partnership, are an important foundation for a collaborative effort in which NHSN, HL7, HL7 consultants, and EHR vendors join forces to advance the field of electronic ADE reporting. These long-standing linkages links between public health and vendors can be leveraged in ways that yield benefits for surveillance and prevention that are tightly coupled to business models and growth. ## Hypoglycemia The first module, Hypoglycemia, as part of the NHSN Medication Safety Component, enables hospitals to track and benchmark inpatient medication-related hypoglycemia (low blood sugar). Inpatient hypoglycemia can be severe and life-threatening and is associated with longer hospital stays and increased medical costs. Severe hypoglycemia (<40 mg/dL) occurs in 2%-5% of hospitalized patients with diabetes mellitus (DM). Medication-related hypoglycemic events are common causes of adverse drug events (ADEs) occurring in inpatient settings, with rates of severe hypoglycemia varying across hospitals, suggesting opportunities for improvement in the quality of care. Measurement of medication-related hypoglycemia in a meaningful and standardized way may improve glycemic management. The NHSN ADE – Hypoglycemia Module provides a mechanism for facilities to report and analyze medication-related hypoglycemia as part of patient safety and glycemic management quality improvement efforts. The hypoglycemia module is based on quality reporting metrics previously- or currently-endorsed by the National Quality Forum (NQF): NQF #2363 Glycemic Control - Hypoglycemia and NQF #3503 Hospital Harm – Severe Hypoglycemia. The metrics reported in this module would be primarily based on linked eMAR (antidiabetic medication administration) and laboratory (blood glucose) data. ## Hyperglycemia This work is now being extended to include the hyperglycemia (high blood sugar) model. Similar to inpatient hypoglycemia, hyperglycemia in hospitalized patients is associated with excess morbidity, mortality, and medical costs. Patients with diabetes comprise 30% to 40% of U.S. hosptial admissions and 70% to 80% of critical care stays. In patients with and without diabetes, appropriate management of hyperglycemia in hospital settings has been associated with improved clinical outcomes, reduced hospital-related morbidity and mortality, and lower costs. The incorporation of hyperglycemia surveillance is important for ensuring a comprehensive and balanced glycemic management quality improvement effort for hospitals. The NHSN ADE – Glycemic Control Module would provide a mechanism for facilities to report and analyze both inpatient hypoglycemia and hyperglycemia as part of patient safety and glycemic management quality improvement efforts. The hyperglycemia module is based on quality reporting metrics currently-endorsed by the National Quality Forum (NQF): NQF #3533e Hospital Harm – Severe Hyperglycemia. The metrics reported in this module are intended to be based on linked diabetes diagnosis, eMAR (antidiabetic medication administration) and laboratory (blood glucose) data. |
No resources found
No resources found
Note: links and images are rebased to the (stated) source
The official URL for this implementation guide is:
http://hl7.org/fhir/us/nhsn-ade/ImplementationGuide/hl7.fhir.us.nhsn-ade
Adverse drug events (ADEs) are among the most common causes of iatrogenic harm in U.S. hospitals. An effort to establish an EHR- and vendor-neutral standard for submitting ADE data to NHSN is being sought to improve patient safety and facilitate quality improvement effort. This promising initiative enables EHRs of acute care facilities to serve as source systems for reporting ADE data to the National Healthcare Safety Network (NHSN) via industry electronic messages. This initiative leverages NHSN’s longstanding experience working closely with the Health Level Seven (HL7) standards development organization and HL7 consultants in developing and maintaining electronic healthcare-associated and antibiotic use and resistance reporting implementation guidance for EHRs and infection surveillance system vendors in the acute care arena. That experience, and the working relationships developed over a 10-year partnership, are an important foundation for a collaborative effort in which NHSN, HL7, HL7 consultants, and EHR vendors join forces to advance the field of electronic ADE reporting. These long-standing linkages links between public health and vendors can be leveraged in ways that yield benefits for surveillance and prevention that are tightly coupled to business models and growth.
The first module, Hypoglycemia, as part of the NHSN Medication Safety Component, enables hospitals to track and benchmark inpatient medication-related hypoglycemia (low blood sugar). Inpatient hypoglycemia can be severe and life-threatening and is associated with longer hospital stays and increased medical costs. Severe hypoglycemia (<40 mg/dL) occurs in 2%-5% of hospitalized patients with diabetes mellitus (DM). Medication-related hypoglycemic events are common causes of adverse drug events (ADEs) occurring in inpatient settings, with rates of severe hypoglycemia varying across hospitals, suggesting opportunities for improvement in the quality of care. Measurement of medication-related hypoglycemia in a meaningful and standardized way may improve glycemic management. The NHSN ADE – Hypoglycemia Module provides a mechanism for facilities to report and analyze medication-related hypoglycemia as part of patient safety and glycemic management quality improvement efforts.
The hypoglycemia module is based on quality reporting metrics previously- or currently-endorsed by the National Quality Forum (NQF): NQF #2363 Glycemic Control - Hypoglycemia and NQF #3503 Hospital Harm – Severe Hypoglycemia. The metrics reported in this module would be primarily based on linked eMAR (antidiabetic medication administration) and laboratory (blood glucose) data.
This work is now being extended to include the hyperglycemia (high blood sugar) model. Similar to inpatient hypoglycemia, hyperglycemia in hospitalized patients is associated with excess morbidity, mortality, and medical costs. Patients with diabetes comprise 30% to 40% of U.S. hosptial admissions and 70% to 80% of critical care stays. In patients with and without diabetes, appropriate management of hyperglycemia in hospital settings has been associated with improved clinical outcomes, reduced hospital-related morbidity and mortality, and lower costs. The incorporation of hyperglycemia surveillance is important for ensuring a comprehensive and balanced glycemic management quality improvement effort for hospitals. The NHSN ADE – Glycemic Control Module would provide a mechanism for facilities to report and analyze both inpatient hypoglycemia and hyperglycemia as part of patient safety and glycemic management quality improvement efforts.
The hyperglycemia module is based on quality reporting metrics currently-endorsed by the National Quality Forum (NQF): NQF #3533e Hospital Harm – Severe Hyperglycemia. The metrics reported in this module are intended to be based on linked diabetes diagnosis, eMAR (antidiabetic medication administration) and laboratory (blood glucose) data.
FHIR{
"resourceType" : "ImplementationGuide",
"id" : "hl7.fhir.us.nhsn-ade",
"meta" : {
"versionId" : "38",
"lastUpdated" : "2022-01-10T02:30:42.699+00:00",
"source" : "#D9XCEKzgl52OE2oZ"
},
"text" : {
"status" : "extensions",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><h2>AdverseDrugEventsGlycemicControl</h2><p>The official URL for this implementation guide is: </p><pre>http://hl7.org/fhir/us/nhsn-ade/ImplementationGuide/hl7.fhir.us.nhsn-ade</pre><div><p>Adverse drug events (ADEs) are among the most common causes of iatrogenic harm in U.S. hospitals. An effort to establish an EHR- and vendor-neutral standard for submitting ADE data to NHSN is being sought to improve patient safety and facilitate quality improvement effort. This promising initiative enables EHRs of acute care facilities to serve as source systems for reporting ADE data to the National Healthcare Safety Network (NHSN) via industry electronic messages. This initiative leverages NHSN’s longstanding experience working closely with the Health Level Seven (HL7) standards development organization and HL7 consultants in developing and maintaining electronic healthcare-associated and antibiotic use and resistance reporting implementation guidance for EHRs and infection surveillance system vendors in the acute care arena. That experience, and the working relationships developed over a 10-year partnership, are an important foundation for a collaborative effort in which NHSN, HL7, HL7 consultants, and EHR vendors join forces to advance the field of electronic ADE reporting. These long-standing linkages links between public health and vendors can be leveraged in ways that yield benefits for surveillance and prevention that are tightly coupled to business models and growth.</p>\n<h2>Hypoglycemia</h2>\n<p>The first module, Hypoglycemia, as part of the NHSN Medication Safety Component, enables hospitals to track and benchmark inpatient medication-related hypoglycemia (low blood sugar). Inpatient hypoglycemia can be severe and life-threatening and is associated with longer hospital stays and increased medical costs. Severe hypoglycemia (&lt;40 mg/dL) occurs in 2%-5% of hospitalized patients with diabetes mellitus (DM). Medication-related hypoglycemic events are common causes of adverse drug events (ADEs) occurring in inpatient settings, with rates of severe hypoglycemia varying across hospitals, suggesting opportunities for improvement in the quality of care. Measurement of medication-related hypoglycemia in a meaningful and standardized way may improve glycemic management. The NHSN ADE – Hypoglycemia Module provides a mechanism for facilities to report and analyze medication-related hypoglycemia as part of patient safety and glycemic management quality improvement efforts.</p>\n<p>The hypoglycemia module is based on quality reporting metrics previously- or currently-endorsed by the National Quality Forum (NQF): NQF #2363 Glycemic Control - Hypoglycemia and NQF #3503 Hospital Harm – Severe Hypoglycemia. The metrics reported in this module would be primarily based on linked eMAR (antidiabetic medication administration) and laboratory (blood glucose) data.</p>\n<h2>Hyperglycemia</h2>\n<p>This work is now being extended to include the hyperglycemia (high blood sugar) model. Similar to inpatient hypoglycemia, hyperglycemia in hospitalized patients is associated with excess morbidity, mortality, and medical costs. Patients with diabetes comprise 30% to 40% of U.S. hosptial admissions and 70% to 80% of critical care stays. In patients with and without diabetes, appropriate management of hyperglycemia in hospital settings has been associated with improved clinical outcomes, reduced hospital-related morbidity and mortality, and lower costs. The incorporation of hyperglycemia surveillance is important for ensuring a comprehensive and balanced glycemic management quality improvement effort for hospitals. The NHSN ADE – Glycemic Control Module would provide a mechanism for facilities to report and analyze both inpatient hypoglycemia and hyperglycemia as part of patient safety and glycemic management quality improvement efforts.</p>\n<p>The hyperglycemia module is based on quality reporting metrics currently-endorsed by the National Quality Forum (NQF): NQF #3533e Hospital Harm – Severe Hyperglycemia. The metrics reported in this module are intended to be based on linked diabetes diagnosis, eMAR (antidiabetic medication administration) and laboratory (blood glucose) data.</p>\n</div></div>"
},
"url" : "http://hl7.org/fhir/us/nhsn-ade/ImplementationGuide/hl7.fhir.us.nhsn-ade",
"version" : "0.1.0",
"name" : "AdverseDrugEventsGlycemicControl",
"title" : "NHSN Reporting: Adverse Drug Events - Glycemic Control",
"status" : "draft",
"date" : "2022-01-10T05:39:41+00:00",
"publisher" : "HL7 International - Public Health Work Group",
"contact" : [
{
"name" : "HL7 International - Public Health",
"telecom" : [
{
"system" : "url",
"value" : "http://www.hl7.org/Special/committees/pher"
}
]
}
],
"description" : "Adverse drug events (ADEs) are among the most common causes of iatrogenic harm in U.S. hospitals. An effort to establish an EHR- and vendor-neutral standard for submitting ADE data to NHSN is being sought to improve patient safety and facilitate quality improvement effort. This promising initiative enables EHRs of acute care facilities to serve as source systems for reporting ADE data to the National Healthcare Safety Network (NHSN) via industry electronic messages. This initiative leverages NHSN’s longstanding experience working closely with the Health Level Seven (HL7) standards development organization and HL7 consultants in developing and maintaining electronic healthcare-associated and antibiotic use and resistance reporting implementation guidance for EHRs and infection surveillance system vendors in the acute care arena. That experience, and the working relationships developed over a 10-year partnership, are an important foundation for a collaborative effort in which NHSN, HL7, HL7 consultants, and EHR vendors join forces to advance the field of electronic ADE reporting. These long-standing linkages links between public health and vendors can be leveraged in ways that yield benefits for surveillance and prevention that are tightly coupled to business models and growth.\n\n## Hypoglycemia\n\nThe first module, Hypoglycemia, as part of the NHSN Medication Safety Component, enables hospitals to track and benchmark inpatient medication-related hypoglycemia (low blood sugar). Inpatient hypoglycemia can be severe and life-threatening and is associated with longer hospital stays and increased medical costs. Severe hypoglycemia (<40 mg/dL) occurs in 2%-5% of hospitalized patients with diabetes mellitus (DM). Medication-related hypoglycemic events are common causes of adverse drug events (ADEs) occurring in inpatient settings, with rates of severe hypoglycemia varying across hospitals, suggesting opportunities for improvement in the quality of care. Measurement of medication-related hypoglycemia in a meaningful and standardized way may improve glycemic management. The NHSN ADE – Hypoglycemia Module provides a mechanism for facilities to report and analyze medication-related hypoglycemia as part of patient safety and glycemic management quality improvement efforts.\n\nThe hypoglycemia module is based on quality reporting metrics previously- or currently-endorsed by the National Quality Forum (NQF): NQF #2363 Glycemic Control - Hypoglycemia and NQF #3503 Hospital Harm – Severe Hypoglycemia. The metrics reported in this module would be primarily based on linked eMAR (antidiabetic medication administration) and laboratory (blood glucose) data.\n\n## Hyperglycemia\n\nThis work is now being extended to include the hyperglycemia (high blood sugar) model. Similar to inpatient hypoglycemia, hyperglycemia in hospitalized patients is associated with excess morbidity, mortality, and medical costs. Patients with diabetes comprise 30% to 40% of U.S. hosptial admissions and 70% to 80% of critical care stays. In patients with and without diabetes, appropriate management of hyperglycemia in hospital settings has been associated with improved clinical outcomes, reduced hospital-related morbidity and mortality, and lower costs. The incorporation of hyperglycemia surveillance is important for ensuring a comprehensive and balanced glycemic management quality improvement effort for hospitals. The NHSN ADE – Glycemic Control Module would provide a mechanism for facilities to report and analyze both inpatient hypoglycemia and hyperglycemia as part of patient safety and glycemic management quality improvement efforts.\n\nThe hyperglycemia module is based on quality reporting metrics currently-endorsed by the National Quality Forum (NQF): NQF #3533e Hospital Harm – Severe Hyperglycemia. The metrics reported in this module are intended to be based on linked diabetes diagnosis, eMAR (antidiabetic medication administration) and laboratory (blood glucose) data.",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "US",
"display" : "United States of America"
}
],
"text" : "United States of America"
}
],
"packageId" : "hl7.fhir.us.nhsn-ade",
"license" : "CC0-1.0",
"fhirVersion" : [
"4.0.1"
],
"dependsOn" : [
{
"id" : "hl7fhiruscore",
"uri" : "http://hl7.org/fhir/us/core/ImplementationGuide/hl7.fhir.us.core",
"packageId" : "hl7.fhir.us.core",
"version" : "4.0.0"
},
{
"id" : "usnlmvsac",
"uri" : "http://fhir.org/packages/us.nlm.vsac/ImplementationGuide/us.nlm.vsac",
"packageId" : "us.nlm.vsac",
"version" : "0.4.0"
}
],
"definition" : {
"extension" : [
{
"extension" : [
{
"url" : "code",
"valueString" : "path-expansion-params"
},
{
"url" : "value",
"valueString" : "expansion-parameters-ade.xml"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "copyrightyear"
},
{
"url" : "value",
"valueString" : "2020+"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "releaselabel"
},
{
"url" : "value",
"valueString" : "CI Build"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "path-liquid"
},
{
"url" : "value",
"valueString" : "template/liquid"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "path-liquid"
},
{
"url" : "value",
"valueString" : "input/liquid"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "path-qa"
},
{
"url" : "value",
"valueString" : "temp/qa"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "path-temp"
},
{
"url" : "value",
"valueString" : "temp/pages"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "path-output"
},
{
"url" : "value",
"valueString" : "output"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "path-suppressed-warnings"
},
{
"url" : "value",
"valueString" : "input/ignoreWarnings.txt"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "path-history"
},
{
"url" : "value",
"valueString" : "http://hl7.org/fhir/us/nhsn-ade/history.html"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "template-html"
},
{
"url" : "value",
"valueString" : "template-page.html"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "template-md"
},
{
"url" : "value",
"valueString" : "template-page-md.html"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "apply-contact"
},
{
"url" : "value",
"valueString" : "true"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "apply-context"
},
{
"url" : "value",
"valueString" : "true"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "apply-copyright"
},
{
"url" : "value",
"valueString" : "true"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "apply-jurisdiction"
},
{
"url" : "value",
"valueString" : "true"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "apply-license"
},
{
"url" : "value",
"valueString" : "true"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "apply-publisher"
},
{
"url" : "value",
"valueString" : "true"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "apply-version"
},
{
"url" : "value",
"valueString" : "true"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
},
{
"extension" : [
{
"url" : "code",
"valueString" : "active-tables"
},
{
"url" : "value",
"valueString" : "true"
}
],
"url" : "http://hl7.org/fhir/tools/StructureDefinition/ig-parameter"
}
],
"resource" : [
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "CodeSystem"
}
],
"reference" : {
"reference" : "CodeSystem/CodeSystem-ade-codes",
"display" : "ADE Code System"
},
"name" : "ADE Code System",
"description" : "This code system contains codes for use in NHSN ADE.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "Bundle"
}
],
"reference" : {
"reference" : "Bundle/bundle-document-ade"
},
"name" : "Bundle - ADE Hypoglycemia example",
"description" : "Example of an ADE Hypoglycemia Bundle",
"exampleBoolean" : true
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "StructureDefinition:resource"
}
],
"reference" : {
"reference" : "StructureDefinition/Composition-ade-hyperglycemia",
"display" : "Composition - ADE Hyperglycemia"
},
"name" : "Composition - ADE Hyperglycemia",
"description" : "This profile supports the electronic submission of adverse drug event (ADE) data relating to hyperglycemia to the National Healthcare Safety Network (NHSN).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "StructureDefinition:resource"
}
],
"reference" : {
"reference" : "StructureDefinition/Composition-ade-hypoglycemia",
"display" : "Composition - ADE Hypoglycemia"
},
"name" : "Composition - ADE Hypoglycemia",
"description" : "This profile supports the electronic submission of adverse drug event (ADE) data relating to hypoglycemia to the National Healthcare Safety Network (NHSN).",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "Composition"
}
],
"reference" : {
"reference" : "Composition/composition-ade-hypoglycemia-example",
"display" : "Adverse Event Note"
},
"name" : "Composition - ADE Hypoglycemia [Harry Hypoglycemic]",
"description" : "Example of Composition-ade-hypoglycemia profile (Harry Hypoglycemic)",
"exampleCanonical" : "http://hl7.org/fhir/us/nhsn-ade/StructureDefinition/Composition-ade-hypoglycemia"
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "Composition"
}
],
"reference" : {
"reference" : "Composition/composition-ade-hypoglycemia-example-2",
"display" : "Adverse Event Note"
},
"name" : "Composition - ADE Hypoglycemia [Name 'masked']",
"description" : "Example of Composition-ade-hypoglycemia profile (Name 'masked')",
"exampleCanonical" : "http://hl7.org/fhir/us/nhsn-ade/StructureDefinition/Composition-ade-hypoglycemia"
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "StructureDefinition:resource"
}
],
"reference" : {
"reference" : "StructureDefinition/Condition-diabetes",
"display" : "Condition Diabetes"
},
"name" : "Condition Diabetes",
"description" : "This Condition profile represents a diagnosis of diabetes",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "StructureDefinition:resource"
}
],
"reference" : {
"reference" : "StructureDefinition/MedicationAdministration-Antidiabetics",
"display" : "MedicationAdministrationAntidiabetics"
},
"name" : "MedicationAdministration - Antidiabetics",
"description" : "This profile represents the administration of an antidiabetic drug.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "MedicationAdministration"
}
],
"reference" : {
"reference" : "MedicationAdministration/medicationadministration-metformin-example"
},
"name" : "MedicationAdministration Antidiabetics [Metformin - Harry Hypoglycemic]",
"description" : "Example of MedicationAdministration-Antidiabetics profile (Harry Hypoglycemic)",
"exampleCanonical" : "http://hl7.org/fhir/us/nhsn-ade/StructureDefinition/MedicationAdministration-Antidiabetics"
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "MedicationAdministration"
}
],
"reference" : {
"reference" : "MedicationAdministration/medicationadministration-metformin-er"
},
"name" : "MedicationAdministration Antidiabetics [Metformin ER - Name 'masked']",
"description" : "Example of MedicationAdministration-Antidiabetics profile (Name 'masked')",
"exampleCanonical" : "http://hl7.org/fhir/us/nhsn-ade/StructureDefinition/MedicationAdministration-Antidiabetics"
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "StructureDefinition:resource"
}
],
"reference" : {
"reference" : "StructureDefinition/Observation-lab-blood-glucose",
"display" : "Observation Laboratory Blood Glucose"
},
"name" : "Observation - Laboratory Blood Glucose",
"description" : "This profile represents a blood glucose lab test.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "Observation"
}
],
"reference" : {
"reference" : "Observation/observation-lab-ade"
},
"name" : "Observation Lab ADE [Glucose - 1 hr post meal - Name 'masked']",
"description" : "Example of Observation-lab-blood-glucose profile (Name 'masked')",
"exampleCanonical" : "http://hl7.org/fhir/us/nhsn-ade/StructureDefinition/Observation-lab-blood-glucose"
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "Observation"
}
],
"reference" : {
"reference" : "Observation/observation-lab-ade-hh"
},
"name" : "Observation Lab Blood Gluclose [Harry Hypoglycemia]",
"description" : "Example of Observation-lab-blood-glucose profile [Fasting glucose [Mass/volume] in Capillary blood - Harry Hypoglycemia]",
"exampleCanonical" : "http://hl7.org/fhir/us/nhsn-ade/StructureDefinition/Observation-lab-blood-glucose"
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "Condition"
}
],
"reference" : {
"reference" : "Condition/condition-diabetes-ade"
},
"name" : "US Core Condition [Diabetes - Name 'masked']",
"description" : "Example of us-core-condition profile (Name 'masked')",
"exampleBoolean" : true
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "Encounter"
}
],
"reference" : {
"reference" : "Encounter/encounter-inpatient-example"
},
"name" : "US Core Encounter [Inpatient - Harry Hypoglycemic]",
"description" : "Example of us-core-encounter profile (Harry Hypoglycemic)",
"exampleBoolean" : true
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "Encounter"
}
],
"reference" : {
"reference" : "Encounter/encounter-completed-inpatient-ade-1"
},
"name" : "US Core Encounter [Inpatient - Name 'masked']",
"description" : "Example of us-core-encounter profile (Name 'masked')",
"exampleBoolean" : true
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "Location"
}
],
"reference" : {
"reference" : "Location/location-salem-medical-center-ade",
"display" : "Clinic Bldg A, Salem Medical Center"
},
"name" : "US Core Location [Clinic Bldg A, Salem Medical Center]",
"description" : "Example of us-core-location profile (Clinic Bldg A, Salem Medical Center)",
"exampleBoolean" : true
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "Organization"
}
],
"reference" : {
"reference" : "Organization/organization-acme-laboratory-ade",
"display" : "Acme_Labs"
},
"name" : "US Core Organization [Acme Labs]",
"description" : "Example of us-core-organization profile (Acme Labs)",
"exampleBoolean" : true
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "Organization"
}
],
"reference" : {
"reference" : "Organization/organization-hospital-physician-group-example",
"display" : "Hospitalists of the World"
},
"name" : "US Core Organization [Hospitalists of the World]",
"description" : "Example of us-core-organization profile (Hospitalists of the World)",
"exampleBoolean" : true
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "Organization"
}
],
"reference" : {
"reference" : "Organization/organization-salem-medical-center-ade",
"display" : "Salem Medical Center"
},
"name" : "US Core Organization [Salem Medical Center]",
"description" : "Example of us-core-organization profile (Salem Medical Center)",
"exampleBoolean" : true
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "Patient"
}
],
"reference" : {
"reference" : "Patient/patient-harry-hypoglycemic-example"
},
"name" : "US Core Patient [Harry Hypoglycemic]",
"description" : "Example of us-core-patient profile (Harry Hypoglycemic)",
"exampleBoolean" : true
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "Patient"
}
],
"reference" : {
"reference" : "Patient/patient-ade-1"
},
"name" : "US Core Patient [Name 'masked']",
"description" : "Example of us-core-patient profile (Name 'masked')",
"exampleBoolean" : true
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "Practitioner"
}
],
"reference" : {
"reference" : "Practitioner/practitioner-ed-endocrinols-example"
},
"name" : "US Core Practitioner [Ed Endocrinols]",
"description" : "Example of us-core-practitioner profile (Ed Endocrinols)",
"exampleBoolean" : true
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "StructureDefinition:resource"
}
],
"reference" : {
"reference" : "StructureDefinition/Observation-diagnosis-ersd-esld-count",
"display" : "Observation - Diagnosis ERSD/ESLD Count"
},
"name" : "Observation - Diagnosis ERSD/ESLD Count",
"description" : "This profile represents the count of all patients hospitalized during a specified time period who meet the criteria of ESRD/ESLD diagnoses (primary or secondary position), irrespective of whether they have experienced an adverse event.",
"exampleBoolean" : false
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/tools/StructureDefinition/resource-information",
"valueString" : "StructureDefinition:resource"
}
],
"reference" : {
"reference" : "StructureDefinition/Observation-diagnosis-diabetes-count",
"display" : "Observation - Diagnosis Diabetes Count"
},
"name" : "Observation - Diagnosis Diabetes Count",
"description" : "This profile represents the count of all patients hospitalized during a specified time period who meet the criteria of Diabetes diagnoses (primary or secondary position), irrespective of whether they have experienced an adverse event.",
"exampleBoolean" : false
}
],
"page" : {
"nameUrl" : "index.html",
"title" : "Home Page",
"generation" : "markdown",
"page" : [
{
"nameUrl" : "background.html",
"title" : "Background",
"generation" : "markdown"
},
{
"nameUrl" : "downloads.html",
"title" : "Downloads",
"generation" : "markdown"
}
]
},
"parameter" : [
{
"code" : "path-resource",
"value" : "input/capabilities"
},
{
"code" : "path-resource",
"value" : "input/examples"
},
{
"code" : "path-resource",
"value" : "input/extensions"
},
{
"code" : "path-resource",
"value" : "input/models"
},
{
"code" : "path-resource",
"value" : "input/operations"
},
{
"code" : "path-resource",
"value" : "input/profiles"
},
{
"code" : "path-resource",
"value" : "input/resources"
},
{
"code" : "path-resource",
"value" : "input/vocabulary"
},
{
"code" : "path-resource",
"value" : "input/maps"
},
{
"code" : "path-resource",
"value" : "input/testing"
},
{
"code" : "path-resource",
"value" : "input/history"
},
{
"code" : "path-resource",
"value" : "fsh-generated/resources"
},
{
"code" : "path-pages",
"value" : "template/config"
},
{
"code" : "path-pages",
"value" : "input/images"
},
{
"code" : "path-tx-cache",
"value" : "input-cache/txcache"
}
]
}
}
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.